The price of Avadel Pharmaceuticals plc (NASDAQ:AVDL) shares last traded on Wall Street fell -1.75% to $14.06.
AVDL stock price is now -13.54% away from the 50-day moving average and -0.34% away from the 200-day moving average. The market capitalization of the company currently stands at $1.35B.
Top 5 Artificial Intelligence Stocks to Buy for 2024
By now, you're well aware of the artificial intelligence boom. You know Big Tech has been investing billions of dollars into it.
According to Next Move Strategy Consulting, the AI market – currently valued at about $100 billion – cold grow twenty-fold by 2030 to more than $2 trillion. That means you may want to strongly consider these top AI stocks. Get our free report, "Top 5 AI Stocks to Buy in 2024."
Click here to automatically get the our FREE Report & Special Offer "5 Best AI Stocks to Invest In"
Sponsored
With the price target of $27, Rodman & Renshaw recently initiated with Buy rating for Avadel Pharmaceuticals plc (NASDAQ: AVDL). On March 05, 2024, Oppenheimer reiterated its ‘Outperform’ rating on the stock by increasing its target price from $27 to quote $29, while ‘Needham’ rates the stock as ‘Buy’
In other news, MCHUGH THOMAS S, Chief Financial Officer bought 2,000 shares of the company’s stock on Jan 16 ’24. The stock was bought for $29,000 at an average price of $14.50. Upon completion of the transaction, the Chief Financial Officer now directly owns 80,500 shares in the company, valued at $1.13 million. An SEC document containing details of the transaction can be found on the SEC’s website. On Dec 28 ’23, Director McCamish Mark Anthony sold 75,000 shares of the business’s stock. A total of $1,089,750 was realized by selling the stock at an average price of $14.53. This leaves the insider owning 67,025 shares of the company worth $0.94 million. A total of 4.64% of the company’s stock is owned by insiders.
During the past 12 months, Avadel Pharmaceuticals plc has had a low of $9.50 and a high of $19.09. As of last week, the company has a debt-to-equity ratio of 0.47, a current ratio of 2.85, and a quick ratio of 2.60. The fifty day moving average price for AVDL is $16.1836 and a two-hundred day moving average price translates $14.11475 for the stock.
The latest earnings results from Avadel Pharmaceuticals plc (NASDAQ: AVDL) was released for 2024-03-31. The net profit margin was -284.42% and return on equity was -779.92% for AVDL.
